What Is Juvenile Idiopathic Arthritis (JIA)?
Juvenile rheumatoid arthritis, also known as juvenile idiopathic arthritis, is the most common type of arthritis in children under the age of 17. Juvenile rheumatoid arthritis causes persistent joint pain, swelling and stiffness. Some children may experience symptoms for only a few months, while others have symptoms for the rest of their lives. It occurs more often in girls.
At this time, there is no known way to prevent JIA. Unfortunately, there is no cure for juvenile arthritis.
Psoriatic arthritis can be treated with a number of different medicines.
If it is untreated, JIA can lead to:
- Loss of vision or decreased vision due to iridocyclitis/uveitis
- Permanent damage to joints
- Chronic arthritis and disability (loss of function)
- Interference with a child’s bone growth
- Inflammation of the membranes surrounding the heart (pericarditis) or lungs (pleuritis)
The goal should be aimed to relieve inflammation, control pain and improve your child’s quality of life. Most treatment plans include a combination of medication, physical activity, eye care and healthy eating. In JIA, there is excessive production of certain proteins such as TNF which causes joint pain, stiffness and damage of joints.
- Nonsteroidal Anti-Inflammatory Drugs (NSAIDs)
- Corticosteroids
- Disease-modifying antirheumatic drugs (DMARDs) like methotrexate
- Biologic DMARDs
Exemptia (contains adalimumab) is one such biological DMARD which blocks TNF-α , which causes inflammation and tissue damage.